Results 91 to 100 of about 64,761 (239)

An Economic Evaluation of Voriconazole versus Amphotericin B for the Treatment of Invasive Aspergillosis in Canada

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2004
BACKGROUND: Invasive aspergillosis (IA) is a serious fungal infection that affects immunocompromised patients. The Global Comparative Aspergillosis study demonstrated that voriconazole, a new broad-spectrum triazole, had better responses and improved ...
Coleman Rotstein   +3 more
doaj   +1 more source

Treatment of invasive aspergillosis in kidney transplant recipients (a clinical case and a literature review) [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия
Invasive aspergillosis is a serious disease that can occur in organ transplant recipients. Most often, this complication develops in recipients of lung, heart, and liver transplants.
Khostelidi S.N.   +10 more
doaj   +1 more source

Aspergillus spondylodiscitis in a patient with liver cirrhosis and diabetes mellitus

open access: yesZdravniški Vestnik, 2014
Aspergillus osteomyelitis is a rare manifestation of invasive aspergillosis which accounts for 1.8% to 5.6% of all invasive aspergillosis forms. As other forms of invasive aspergillosis, it predominantly occurs in immunosupressed patients with well ...
Tereza Rojko   +4 more
doaj  

Estimated Burden of Serious Fungal Infections in Mozambique

open access: yesJournal of Fungi, 2018
Mozambique is a sub-Saharan African country with limited information on the burden of fungal disease. We estimate the burden of serious fungal infections for the general healthy population and for those at risk, including those infected with HIV ...
Jahit Sacarlal, David W. Denning
doaj   +1 more source

Is fungal disease in Sri Lanka underestimated? A comparison of reported fungal infections with estimated disease burden using global data

open access: yesSri Lankan Journal of Infectious Diseases, 2015
IntroductionWith an increase in the elderly population and developments in medical care, increased numbers of patients with fungal diseases are expected.
P.I. Jayasekera   +4 more
doaj   +1 more source

Transforming Care in Cystic Fibrosis: The Long‐Term Impact of Quality Improvement Projects on Clinical Outcomes

open access: yesPediatric Pulmonology, Volume 61, Issue 4, April 2026.
ABSTRACT Objective This study aimed to evaluate 5‐year outcomes of a structured quality improvement (QI) program implemented as part of the standard of care at our CF center, focusing on changes in body mass index (BMI) and forced expiratory volume in 1 s (FEV₁) in pwCF followed at our institution.
S. Karabulut   +14 more
wiley   +1 more source

An evolutionary perspective on zinc uptake by human fungal pathogens [PDF]

open access: yes, 2015
DW is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 102549/Z/13/Z).Peer reviewedPublisher ...
Wilson, Duncan
core   +1 more source

Clinico-immunological features of invasive aspergillosis in patients with Hodgkin’s disease

open access: yesКлиническая онкогематология, 2014
Invasive aspergillosis is a serious mycotic infection with high mortality that mostly occurs in patients with hematological malignancies and severe immunodeficiency.
O. V. Shadrivova   +15 more
doaj   +1 more source

Pulmonary aspergillosis

open access: yesDiagnostic and Interventional Imaging, 2015
Aspergillosis is a mycotic disease usually caused by Aspergillus fumigatus, a saprophytic and ubiquitous airborne fungus. Aspergillus-related lung diseases are traditionally classified into four different forms, whose occurrence depends on the immunologic status of the host and the existence of an underlying lung disease.
Chabi, M.L.   +5 more
openaire   +2 more sources

Electronic health records improve the diagnosis and prognosis of pulmonary fungal infections in lung cancer patients

open access: yesVIEW, Volume 7, Issue 2, April 2026.
Pulmonary fungal infections are life‐threatening complications in lung cancer patients, posing significant challenges in clinical management. To address this, we developed machine learning tools that translate routine electronic health record data into actionable insights for diagnosing infections and assessing prognosis.
Hongwei Meng   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy